Mark For: CYCLACEL™ trademark registration is intended to cover the categories of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 97613039 |
Mark Literal Elements | CYCLACEL |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | Trademark, Service Mark |
Current Location | NEW APPLICATION PROCESSING 2022-10-03 |
Basis | 1(a) 44(e) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | Yes |
Current Use | Yes |
Intent To Use | No |
Filed ITU | No |
44D Filed | No |
44E Current | Yes |
66A Current | No |
Current Basis | No |
No Basis | No |
Domestic Representative | Jeffrey A. Smith |
Attorney Name | Jeffrey A. Smith |
Attorney Docket Number | DYOUNG-65-T |
1997-08-29 | Trademark Registered |
1997-08-31 | Date of First Use |
2003-09-30 | Date of Use In Commerce |
2022-09-29 | Application Filed |
2022-10-03 | Location: NEW APPLICATION PROCESSING |
2022-10-03 | Status: Live/Pending |
2022-10-03 | Status: New application awaiting assignment to an examining attorney. See current trademark processing wait times for more information. |
2022-10-03 | Transaction Date |
Party: | ![]() |
Address | 2 London Wall Place London ENGLAND EC2Y5AU |
Legal Entity Type | Company |
Legal Entity State | UNITED KINGDOM |
![]() | 2022-09-29 | |
![]() | 2022-09-29 | |
![]() | 2022-09-29 |
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical substances and preparations for the treatment of cancer, hematological disorders; pharmaceutical substances and preparations for use in oncology, hematology; medical preparations for the treatment of cancer and hematological disorders; medical substances in the nature of pharmaceuticals for the treatment of oncological diseases and preparations for use in oncology; medicinal preparations for the treatment of cancer and hematological disorders; medical substances in the nature of pharmaceuticals for the treatment of cancer and hematological disorders; preparations for human use for the treatment of cancer and hematological disorders |
GS0051 | Pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical substances and preparations for the treatment of cancer, hematological disorders; pharmaceutical substances and preparations for use in oncology, hematology; medical preparations for the treatment of cancer and hematological disorders; medical substances in the nature of pharmaceuticals for the treatment of oncological diseases and preparations for use in oncology; medicinal preparations for the treatment of cancer and hematological disorders; medical substances in the nature of pharmaceuticals for the treatment of cancer and hematological disorders; pharmaceutical preparations for human use for the treatment of cancer and hematological disorders |
Description | Date | Proceeding Number |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2022-10-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.